Allen Klee

Managing Director, Senior Equity Research Analyst


Maxim Group

Allen Klee is a Managing Director and Senior Equity Research Analyst at Maxim Group, LLC covering tech, telecom, media, and healthcare technology. Prior to joining Maxim, Mr. Klee was a Managing Director, Equity Analyst covering TMT at National Securities Corporation. Prior sell-side experience included working at Maxim Group as an SVP of Equity Research and Sidoti & Company, LLC as a Senior Equity Analyst also covering TMT. Other experience includes buy-side roles as a Prop Trader at Xanthus Capital, Equity Analyst at both Casey Capital and Sigma Capital, and as a Portfolio Manager for small and midcap mutual funds at both First Investors Corporation and Guardian Life Insurance. Prior to that, Mr. Klee was a Senior Credit Analyst at both Guardian Life Insurance and at Moody’s Investor Service. Mr. Klee earned his MBA in Finance from the NYU Stern School of Business and has a B.S. from Rutgers University with a double major in BioMathematics and Economics. He also holds the CFA designation.


    2:20 PM - 2:50 PM

    Thursday General Session 2/1/2024

    What Microcaps Need to Do to Attract Institutional Investors

    • Lessons learned from raising money for microcap portfolio managers
    • How to digitally market to draw in investors
    • Management quality and track record
    • A good website
    • Well-articulated business model, with key financial metrics institutional investors focus on
    • "Small Cap Giants" and total addressable markets
    • Discipline and capital allocation
    View Full Agenda